PrimeGen Biotech Presents Stem Cell Platforms at Launch of New Bone Marrow Transplant Unit in Ecuador.GUAYAQUIL, Ecuador -- PrimeGen Biotech (http://www.primegenbiotech.com) today announced that it will present results of its stem cell platforms at an event sponsored by the Benemerita Sociedad de Lucha Contra el Cancer History During the 40s, Dr. Juan Tanca Marengo, a distinguished Ecuadorian doctor and humanist, worried about public health and all the different types of cancer, considered that it was necessary for him to share his oncologic knowledge with the medicine students and with (SOLCA) - an Ecuador-based institution to fight cancer. The event will be held Friday, Dec. 15, at Guayaquil's SOLCA Hospital. Francisco J. Silva, vice president of research and development, is presenting "The Present and Future of Stem Cells." He will discuss these platforms developed by the company's subsidiaries, PrimeCell[TM] Therapeutics LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control and NewStem Biosciences LLC, including pre-clinical work using cell-based therapy to treat spinal cord injury Spinal Cord Injury Definition Spinal cord injury is damage to the spinal cord that causes loss of sensation and motor control. Description Approximately 10,000 new spinal cord injuries (SCIs) occur each year in the United States. . The event officially launches a new bone marrow transplant bone marrow transplant: see bone marrow. unit for leukemia patients. The event is expected to draw notables from around the country, including a representative of the newly elected President Rafael Correa, along with well-known hematologists and oncologists. Also presenting are Luis Geffner, M.D., a world-renowned stem cell clinical researcher from Argentina, along with Bella Maldonado (Ecuador), Fernando Hernandez (Spain), Enric Carreras (Spain), Jose M. Moraleda (Spain) and Teodoro Chisesi (Italy). "I'm thrilled to be invited to participate in the launch of this unit that will bring hope to many who suffer from leukemia," said Silva. "PrimeGen is very excited about the stem cell work being performed here in Ecuador. We look forward to collaborating with the Junta de Beneficencia hospitals and SOLCA to further develop stem cell technologies, making Ecuador a global leader for cell-based therapies." About PrimeGen Biotech LLC PrimeGen Biotech LLC is a privately held biotechnology company dedicated to providing the most potent regenerative cells for use in diverse therapeutic applications. Its wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. , PrimeCell[TM] Therapeutics LLC, has developed the first adult stem cell Adult stem cells are undifferentiated cells found throughout the body that divide to replenish dying cells and regenerate damaged tissues. Also known as somatic (from Greek Σωματικรณς, of the body capable of transforming into any cell type found in the body - known as PrimeCell[TM]. PrimeGen's chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Thomas C.K. Yuen is renowned for turning technological promise into successful, leading-edge companies - first as co-founder, co-chairman and COO of AST Research, Inc., then as chairman, CEO and president of SRS Labs. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion